A Superfood and a super supplement all in one, giving your brain and body the Nutrients it needs for optimum daily function.
Riishii Brew is a healthy alternative from coffee and energy drinks, This complex blend of herbs and mushrooms purpose is to give the body that energy boost throughout the day with your best health aids added in mind from ancient natural medicine. It’s extraordinary health benefits includes gut health, immune system aid, cancer preventatives, lowers cholesterol, Improved Cognitive Function, helps depression and anxiety just to name a few with proven studies.
Phase 1
This Product targets all demographics, the holistic community the herbal community the psychedelic community and all individuals that care about their health and prefer natural products to optimize your health. That demand has been increasing significantly in the past five years.
The psychedelic/mushroom and holistic market and is growing rapidly and is becoming an every day use. This is a perfect opportunity to tap into the market with a product like this, when so much money is being invested into psychedelic study research in general and is starting being legalized in the United States slowly like legalized Marijuana in 2012.
The health benefits of these ingredients are absolutely profound, the natural set of ingredients this product has gives the body everything it needs, on top of the phenomenal health aids for disease prevention and so much more.
Phase 2
In the bigger picture the start and growth of this company is the perfect step to start a brand that will have enough funding in years to come to step into the market of legalized psychedelic products/medicine. We want to provide a safe space to offer natural health alternatives to repair the mind, body and brain outside of the pharmaceutical/chemical empire at affordable prices. Though we are early in our journey we want you to be a part of this journey, and spread as much knowledge to you as we can in this process. A new market study of the U.S. psychedelic drug space forecasts that the market is projected to grow at 16.3%. Factors such as increasing prevalence of depression and mental disorders drive that growth. The Data Bridge Market Research report notes that the market is expected to total approximately $6.8 billion by 2027, up from $2 billion in 2019. In addition, the report specifically highlights the growing acceptance of psychedelic drugs for treating depression along with the increasing prevalence of depression and mental disorders as significant factors in that anticipated growth.
We can get into a position to be a valuable player in that market and in the holistic market.
- CEO, Franchesca Buce